Answer
Pradaxa is used for primary prevention of venous thromboembolic events (VTE) in adults after elective total hip replacement or total knee replacement surgery.
Sources for this answer
- Pradaxa 75 mg hard capsulesBoehringer Ingelheim Limited · emc · SmPC §4.1 Therapeutic Indications · Version 47Document updated
Sources checked